Compliance Certificate under Regulation 74(5) for Quarter ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Ltd has submitted a compliance certificate under SEBI's Regulation 74(5) for the quarter ending December 31, 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Cameo Corporate Services Limited. It confirms that all physical share certificates received for dematerialization during the quarter were processed, confirmed to the depositories, mutilated, and cancelled on time, with the depository's name substituted as the registered owner in the company's member register. The filing was made to BSE (Scrip Code: 541299) on January 12, 2026, signed by Managing Director Arjan Lal Chandani.
This is a routine procedural compliance filing required of every listed company each quarter. It has no material impact on shareholders, business operations, or stock price — it simply confirms that share dematerialization requests were handled in line with SEBI rules.